Pavlo Holenya

768 total citations
20 papers, 475 citations indexed

About

Pavlo Holenya is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pavlo Holenya has authored 20 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pavlo Holenya's work include Monoclonal and Polyclonal Antibodies Research (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Mosquito-borne diseases and control (2 papers). Pavlo Holenya is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Mosquito-borne diseases and control (2 papers). Pavlo Holenya collaborates with scholars based in Germany, United Kingdom and United States. Pavlo Holenya's co-authors include Stefan Wölfl, Hamed Alborzinia, Suzan Can, Igor Kitanović, Catharina Scholl, Ingo Ott, Xinlai Cheng, Michael Drosch, Florian Heigwer and Florian Kern and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Pavlo Holenya

20 papers receiving 470 citations

Peers

Countries citing papers authored by Pavlo Holenya

Since Specialization

Citations

This map shows the geographic impact of Pavlo Holenya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavlo Holenya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavlo Holenya more than expected).

Fields of papers citing papers by Pavlo Holenya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavlo Holenya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavlo Holenya. The network helps show where Pavlo Holenya may publish in the future.

Co-authorship network of co-authors of Pavlo Holenya

This figure shows the co-authorship network connecting the top 25 collaborators of Pavlo Holenya. A scholar is included among the top collaborators of Pavlo Holenya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavlo Holenya. Pavlo Holenya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Overview of Peptides and Peptide Pools for Antigen-Specific Stimulation in T-Cell Assays 2024 ·Methods in molecular biology ·Karsten Schnatbaum, Pavlo Holenya, (unknown), Michael Drosch, Maren Eckey, Ulf Reimer, Holger Wenschuh, Florian Kern	1
2	The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread 2023 ·Nature Communications ·Ariane C. Gomes, Ilona Baraniak, (unknown), (unknown), Pavlo Holenya, Claire Atkinson, George Tang, (unknown), Florian Kern, Paul Griffiths, Matthew B. Reeves	18
3	Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients 2023 ·Journal of Translational Medicine ·Anna Lucia Tornesello, (unknown), (unknown), (unknown), (unknown), Maria Antonietta Isgrò, (unknown), (unknown), Ernesta Cavalcanti, (unknown), (unknown), Luigi Atripaldi, Noemy Starita, Andrea Cerasuolo, Ulf Reimer, Pavlo Holenya, Luigi Buonaguro, Maria Lina Tornesello	2
4	Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies 2022 ·Frontiers in Cellular and Infection Microbiology ·Adéla Nacer, (unknown), (unknown), Erkki Juronen, Pavlo Holenya, (unknown), Rogério Amino, Olivier Silvie, Doris Quinkert, Yann Le Duff, Matthew Hurley, Ulf Reimer, Andres Tover, Simon J. Draper, Sarah C. Gilbert, Mei Mei Ho, Paul W. Bowyer	3
5	Peptide microarray‐based analysis of antibody responses to SARS‐CoV‐2 identifies unique epitopes with potential for diagnostic test development 2021 ·European Journal of Immunology ·Pavlo Holenya, (unknown), Ulf Reimer, Wolfram Woltersdorf, (unknown), (unknown), (unknown), Maren Eckey, Michael Drosch, (unknown), Michael Naumann, Florian Kern, Holger Wenschuh, Robert Lange, Karsten Schnatbaum, Frank F. Bier	36
6	Profiling the HCV Immune Response in Patients with Chronic LiverDiseases and Hepatocellular Carcinoma by Peptide MicroarrayAnalysis 2021 ·Current Medicinal Chemistry ·Anna Lucia Tornesello, Ulf Reimer, Pavlo Holenya, Tobias Knaute, Francesca Pezzuto, Francesco Izzo, Luigi Buonaguro, Matteo Megna, Franco M. Buonaguro, Maria Lina Tornesello	1
7	Expression of programmed death ligand (PD-L1) in different tumors. Comparison of several current available antibody clones and antibody profiling 2019 ·Annals of Diagnostic Pathology ·(unknown), (unknown), Michael Drosch, Pavlo Holenya, Ruth Knuechel, Till Braunschweig	32
8	Original Antigenic Sin Shapes the Immunological Repertoire Evoked by Human Cytomegalovirus Glycoprotein B/MF59 Vaccine in Seropositive Recipients 2019 ·The Journal of Infectious Diseases ·Ilona Baraniak, Florian Kern, Pavlo Holenya, Paul Griffiths, Matthew B. Reeves	14
9	A novel peptide pool with broad infectious antigen and MHC coverage for use as a positive stimulation control or as a means to elicit general T-cell responsiveness 2018 ·The Journal of Immunology ·(unknown), Pavlo Holenya, Maren Eckey, M. Schulz, Holger Wenschuh, Ulf Reimer, (unknown), Kam Ming Chan, Janani Ramesh, (unknown), Florian Kern	2
10	Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray 2017 ·PLoS ONE ·Madlen Loebel, Maren Eckey, Franziska Sotzny, (unknown), Sandra Bauer, Patricia Grabowski, Johannes Zerweck, Pavlo Holenya, Leif G. Hanitsch, Kirsten Wittke, Peter Borchmann, (unknown), Falk Hiepe, Klemens Ruprecht, Uta Behrends, (unknown), Hans‐Dieter Volk, Ulf Reimer, Carmen Scheibenbogen	51
11	Multimodal Eph/Ephrin signaling controls several phases of urogenital development 2016 ·Kidney International ·Christiane Peuckert, (unknown), Pavlo Holenya, Derek Adams, Smitha Sreedharan, (unknown), Louise Andersson, Hanna Pettersson, Stefan Wölfl, Rüdiger Klein, Leif Oxburgh, Klas Kullander	11
12	Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs 2016 ·Molecular Oncology ·Xinlai Cheng, Jee Young Kim, Shahrouz Ghafoory, (unknown), (unknown), Jannick Theobald, Hamed Alborzinia, Pavlo Holenya, Johannes Fredebohm, (unknown), Arianeb Mehrabi, Mohammadreza Hafezi, (unknown), Gerhard Eisenbrand, Jörg D. Hoheisel, Stefan Wölfl	40
13	The new facile and straightforward method for the synthesis of 4 H -1,2,3-thiadiazolo[5,4- b ]indoles and determination of their antiproliferative activity 2015 ·European Journal of Medicinal Chemistry ·Nataliya P. Belskaya, (unknown), Vasiliy А. Bakulev, (unknown), Igor Kitanović, Pavlo Holenya, Maksim Zakhartsev, Stefan Wölfl	8
14	Rhodium(I) N-Heterocyclic Carbene Bioorganometallics as in Vitro Antiproliferative Agents with Distinct Effects on Cellular Signaling 2015 ·Journal of Medicinal Chemistry ·Luciano Oehninger, Sarah Spreckelmeyer, Pavlo Holenya, Samuel M. Meier, Suzan Can, Hamed Alborzinia, Julia Schur, Bernhard K. Keppler, Stefan Wölfl, Ingo Ott	40
15	Detailed analysis of pro-apoptotic signaling and metabolic adaptation triggered by a N-heterocyclic carbene–gold(i) complex 2014 ·Metallomics ·Pavlo Holenya, Suzan Can, Riccardo Rubbiani, Hamed Alborzinia, (unknown), Xinlai Cheng, Ingo Ott, Stefan Wölfl	48
16	Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain 2012 ·BMC Genomics ·Catharina Scholl, (unknown), Pavlo Holenya, M. Shaked-Rabi, Kerry L. Tucker, Stefan Wölfl	9
17	KOMA: ELISA-microarray calibration and data analysis based on kinetic signal amplification 2012 ·Journal of Immunological Methods ·Pavlo Holenya, Florian Heigwer, Stefan Wölfl	11
18	Microarray‐based kinetic colorimetric detection for quantitative multiplex protein phosphorylation analysis 2011 ·PROTEOMICS ·Pavlo Holenya, Igor Kitanović, Florian Heigwer, Stefan Wölfl	15
19	Real-Time Monitoring of Cisplatin-Induced Cell Death 2011 ·PLoS ONE ·Hamed Alborzinia, Suzan Can, Pavlo Holenya, Catharina Scholl, (unknown), Igor Kitanović, Stefan Wölfl	87
20	Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties 2010 ·Journal of Cellular and Molecular Medicine ·(unknown), Tobias Langenberg, Anne Mahringer, V. Badireenath Konkimalla, (unknown), Pavlo Holenya, Almut Brand, (unknown), Gert Fricker, Mieke Dewerchin, Peter Carmeliet, Edward M. Conway, Herwig Jansen, Thomas Efferth	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact